42 subscribers
Treceți offline cu aplicația Player FM !
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal)
Manage episode 459573418 series 2739469
We love to hear from our listeners. Send us a message.
Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his time navigating medical affairs as CMO at Moderna during the COVID 19 pandemic to learn about his latest venture, an mRNA startup called Exsilio Therapeutics. We cover the foundational aspects of the company's start, from the science it's developing, who's been recruited to the team, and how Exsilio charted its way to an $82 million Series A co-led by Novartis Venture Fund and Delos Capital, with participation from OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures, and Deep Insight.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Capitole
1. Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal) (00:00:00)
2. Innovative Biotech Funding and Curiosity (00:00:04)
3. Revolutionizing Cancer Treatment Through Biotech (00:12:19)
4. Early Stage Biotech Leadership Insights (00:20:32)
5. Navigating Biotech Funding and Leadership (00:29:20)
6. Advancing Biotech Through Ethical Innovation (00:43:13)
238 episoade
Manage episode 459573418 series 2739469
We love to hear from our listeners. Send us a message.
Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his time navigating medical affairs as CMO at Moderna during the COVID 19 pandemic to learn about his latest venture, an mRNA startup called Exsilio Therapeutics. We cover the foundational aspects of the company's start, from the science it's developing, who's been recruited to the team, and how Exsilio charted its way to an $82 million Series A co-led by Novartis Venture Fund and Delos Capital, with participation from OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures, and Deep Insight.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Capitole
1. Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal) (00:00:00)
2. Innovative Biotech Funding and Curiosity (00:00:04)
3. Revolutionizing Cancer Treatment Through Biotech (00:12:19)
4. Early Stage Biotech Leadership Insights (00:20:32)
5. Navigating Biotech Funding and Leadership (00:29:20)
6. Advancing Biotech Through Ethical Innovation (00:43:13)
238 episoade
Toate episoadele
×1 High-Throughput Discovery With Bioptic's Andrey Dobry 1:13:36
1 RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D. 1:06:32
1 Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal) 54:04
1 Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D. 1:02:34
1 Biotech Story Time With Tal Zaks, M.D. (Part 1) 55:25
1 A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D. 52:50
1 Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski 1:03:50
1 Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D. 45:26
1 T-Cells For The Win With Adaptimmune's Adrian Rawcliffe 1:01:35
1 Serving The Underserved With Gates MRI's Claire Wagner, M.D. 46:48
1 An Unanticipated Biotech Startup With OS Therapies' Paul Romness 49:12
1 Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright 44:14
1 Obesity Tx End-Around With Skye Bioscience's Punit Dhillon 1:02:41
1 Biotech C-Suite Construction With Allan Shaw 51:34
Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.